BEAM

Beam Therapeutics Inc. Common Stock
Data: 2026-08-21

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Quick Stats
Aug 21, 2026

41.9

AI Score

HOLD

1.27

Volume Ratio

TBA

Next Earnings

11

+ve Days (30d)

19

-ve Days (30d)

BEAM Stock Summary

Last updated Aug 21, 2026

BEAM is currently trading at $29.76, positioned above its 200-day moving average of $28.16, indicating a long-term uptrend. The stock has a 52-week range of $15.6 to $38.26.

Technical Analysis: The 50-day moving average stands at $29.9, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 57.987, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.12, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates BEAM at 41.9/100 with a HOLD recommendation.

BEAM (Beam Therapeutics Inc. Common Stock) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 57.987
CMF (20) 0.12
ROC (10) 8.297
ADX (14) 18.557
Indicator Value
MACD (12,26,9) -0.194
AROONOSC (14) 100.0
WILLAMS %R (14) -15.449
MFI (14) 43.518
BEAM Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BEAM Price vs Max Options Open Interest
BEAM Max Change In Options Open Interest

BEAM Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BEAM Daily Out of Money Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BEAM Daily In the Money Options - Sort by Max open Interest (near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BEAM Most Active Options by Volume(near term)

22nd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Beam Therapeutics Inc. Common Stock is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).

BEAM Moving Averages Analysis

Beam Therapeutics Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 21, 2026

BEAM (Beam Therapeutics Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 27.5
20 27.02
30 27.35
50 29.9
100 29.63
200 28.16

BEAM Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 2.9 billion
Earnings/Share ($) -0.69
Net Profit Margin (%) -0.5545
Dividend/Share ($) --
EPS Estimate Current Year ($) -4.4535
EPS Estimate Next Year ($) -4.7414
WallStreet Target Price ($) 52.15
Most Recent Quarter